Barry Dixon

ORCID：0000-0002-5151-1674

发表论文 79 篇 · 总被引 1768 次 · h-index 24

代表论文

• Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial (2021 · The Lancet Respiratory Medicine · 被引 80)
• Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies (2021 · The Lancet Global Health · 被引 45)
• Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID‐19: A multicentre case series of 98 patients (2022 · British Journal of Clinical Pharmacology · 被引 33)
• INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID‐19 (INHALE‐HEP): Protocol and statistical analysis plan for an investigator‐initiated international metatrial of randomised studies (2020 · British Journal of Clinical Pharmacology · 被引 32)
• Assessment of a Non-Invasive Brain Pulse Monitor to Measure Intra-Cranial Pressure Following Acute Brain Injury (2023 · Medical Devices Evidence and Research · 被引 20)
• Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID‐19 Requiring invasive ventilation Meta‐Trial (CHARTER‐MT): Protocol and statistical analysis plan for an investigator‐initiated international meta‐trial of prospective randomised clinical studies (2022 · British Journal of Clinical Pharmacology · 被引 14)